Provision of prescriber specific report on antibiotic prescribing (2018)

Ashford CCG and Canterbury and Coastal CCG

Introduction

The project aims to provide timely, up-to-date progress reports on antibiotic prescribing at practice and individual prescriber level. This allows prescribers to review recent activity in a format which minimises workload for both GP practice staff and CCG Medicine Management teams and supports the national monitoring provided by NHS England's antibiotic Quality Premium (QP) and CCG Improvement and Assessment Framework (IAF).

The reports are published and emailed to practice managers before the 14th of each month. The reports contain all antibiotics prescribed up to the last day of the previous month; up to two months earlier than the ePACT data for the same period, giving practices the opportunity to reflect on recent prescribing and adapt if necessary.

How was the project established? / How is it currently being established?

The project was devised by the joint Medicines Management team at Ashford CCG and Canterbury and Coastal CCG in answer to practice queries about their progress towards the NHS England QP and IAF targets. Data was available from both NHS England and PrescQIPP which suggested that both CCGs had a high number of antibiotic items/STAR PU when compared to the rest of the country.

However these reports have some limitations;

  • They are based on ePACT data which is only available two to three months after the prescribing has taken place (so practices have a short amount of time to adjust prescribing trends)
  • They use 12 month rolling data (which made accurately assessing progress in the early months of the year difficult)
  • They only include prescribing activity at practice level (prescriber-level data was seen as essential when challenging prescribing with clinicians)

While the NHS England and PrescQIPP reports provide an excellent national overview, there was a need for a prompt, localised, granular summary to supplement the national reports.

Realising that the most accurate, up-to-date data is held on the practice clinical systems (EMIS Web and Vision), the Medicines Management team created searches on these systems to find all antibiotic items prescribed in the previous month. These searches are run at each practice on the first of each month and the results are sent to the Medicines Management team.

The EMIS search results are set up to only include the EMIS identification number and age (in years) for each patient. Patient Identifiable Data is included in the Vision results, but is deleted in practice before the results are sent to Medicines Management (only the Vision identification number and age in years are included). Both searches include the name of the antibiotic, quantity and unit, dose, date of issue, authorising GP and issuing user.

(please see full project pack for screenshot)

Two Excel workbooks were created by the Medicines Management team, one for each CCG, to collate all of the monthly search results. The search results by themselves do not provide a clear overview of the prescribing that has taken place, the workbooks are vital to collating, reviewing and presenting the data.

Once the monthly search results have been received they are copied into the corresponding workbook. Excel formulas were written to calculate each practice's progress towards the QP and IAF targets. These formulas are run against every prescription included in the monthly search results and involve;

  • Determining whether the issuing user of each prescription is a prescriber. If the issuing user is not a prescriber, the original authorising user is assigned responsibility for that prescription.
  • Identifying the specific antibiotic prescribed. For example, identifying 'Trimethoprim 100mg tablets' as 'Trimethoprim'.
  • For each specific antibiotic, identifying whether it is co-amoxiclav, a cephalosporin or a quinolone.

The report templates were created with input from the CCG's GP prescribing leads and local Antimicrobial Stewardship Group. The reports are built directly into the Excel files and so update when new data is added.

(please see full project pack for screenshot)

As the data is extracted directly from the clinical systems, a prescriber-level report is also available to practices. The Excel formulas assign any repeat prescription issued by a non-prescriber back to the original authorising prescriber, allowing the prescriber-level report to show each prescriber's progress towards the targets without including a long list of non-prescribing staff.

(please see full project pack for screenshot)

The reports automatically update when new monthly data is added; it is a simple matter to save PDF files each month and email the files to the practice managers/key contacts. One of the CCG's Pharmacists reviews the data before it is published, double-checking the trends and identifying the reasons behind any unusual prescribing. This provides practices with another level of assurance, answering questions before they arise.

There are some limitations to the data when provided in this format:

  • The reports count all prescriptions recorded in the clinical systems. Any delayed prescriptions or items that are not dispensed are therefore counted towards the targets in the CCG reports but are not counted by NHS England.
  • Antibiotics prescribed for patient records marked 'Confidential' are not included, potentially causing the progress to appear lower than it is.
  • Some items prescribed in March 17 (before the target period) may have been dispensed in April 17, and some items prescribed in March 18 may have been dispensed in April 18 (after the target period). These items will be attributed differently in the national reports.
  • Any antibiotics prescribed by non-GP practice providers (Out Of Hours, external clinics, etc.) are not included in the CCG report at present but are included in NHS England's data.

With the exception of the last point, these limitations are estimated to only result in minor variations from the national figures. We also planned to review the difference between the clinical system data and the corresponding ePACT results once the full year's ePACT data was available (results are available in the 'additional information' section below).

Additionally, analysis of prescriber-level data requires an awareness of each prescriber's varying working patterns and the complexity of the patients under their care.

The team's Prescribing Support Technicians have quarterly meetings with the practice management team and GP prescribing leads at each practice. The monthly reports now form a key part of those meetings, alongside the data provided by PrescQIPP and NHS England. The Technicians discuss the practice's progress and challenge areas where the practice appears to be an outlier. The Technicians offer guidance on accessing local guidance and the templates we have devised for the clinical systems (for use in urinary tract infection and sore throat consultations).

At the end of the year (March 18) each practice was sent an action plan showing their progress towards the targets, advising on the following year's targets (if available) and asking practices to reflect on the figures. Anonymised examples of these reports are included with this submission.

Who are the main beneficiaries of the project? How would they benefit?

The main beneficiaries of the project are the prescribers at each GP surgery, although any subsequent reduction in inappropriate antibiotic prescribing may also have a positive effect on patient safety (helping to combat the global challenge of antimicrobial resistance).

The reports allow the CCG, practices and prescribers to analyse trends far earlier than reports based on ePACT data, allowing action plans to be put in place without delay and potentially reducing inappropriate antimicrobial prescribing.

Prescribers:

  • Greater insight into their individual prescribing trends.
  • Comparison against other prescribers within their practice.

Practices:

  • Clear summary of progress towards the QP/IAF targets.
  • Comparison with other local practices which may have similar patient demographics and introduction of friendly competition among peers.
  • Identification of individuals (including locums) who may require signposting to local and national antimicrobial guidance.
  • Resources for internal audits and study days.

CCGs:

  • An additional tool to support appropriate prescribing and attainment of the Quality Premium targets.
  • Reduction in inappropriate antimicrobial prescribing will also have an associated cost benefit.

On a broader scale, there is national public health benefit to implementing a similar project. There is a clear benefit to highlighting individual prescribing trends as it generates increased ownership and reflection.

What were the main outcomes and / or achievements of the project?

The first report was published in September 2017 and has been published on a monthly basis since. Outcomes for the project are difficult to measure as any changes in antibiotic prescribing are likely to be due to a number of factors. Additionally the release of the reports coincided with the annual increase in antibiotics seen during the winter months.

However, the GP practices in Ashford CCG met all but one of the 2017-18 QP & IAF targets, and the GP practices in Canterbury and Coastal CCG met all of the targets (some were achieved with a considerable margin).

(please see full project pack for outcomes table)

The overview files have also received excellent feedback from practices:

  • “There was a steady improvement throughout the year, culminating in a good reduction in ratio to below that of the CCG. This was brought about by regular feedback to prescribers based on the monthly reports produced by [Medicines Management]. This was in the form of emails direct to individual prescribers when areas for improvement were identified, and also quarterly meetings involving all clinical staff where the information was shared, and action points agreed upon.” – GP practice prescribing lead
  • “The issue of antibiotic prescribing is discussed regularly at our practice meetings. I also forward antibiotic reports to all the other doctors at the practice so they can reflect on their prescribing. This is particularly important as we have had new doctors starting at our surgery in the last year and a change of Gp Registrars.” – GP
  • “In the early part of the 2017 data it shows our antibiotic use was much higher than the CCG target. This was highlighted to me in mid 2017 by the prescribing team. I therefore took this seriously and did lots of work trying to reduce the figures.” – GP
  • “Thank you […] for the work you have done on the new quality premium data, the feedback I've had from Ashford practices so far has been really positive and they seem to actually be looking at the data and changes they need to make!” – Prescribing Support Technician

Following the release of the March 2018 ePACT data, we were able to compare the number of antibiotic items prescribed (included in the EMIS/Vision data) and dispensed (included in the ePACT data) over the 2017/18 financial year. Due to the limitation of the clinical system data, this comparison was essential in determining the accuracy of the CCG’s reports compared to the national reports.

(please see full project pack for table)

As mentioned, there are some limitations to the EMIS/Vision data but the table above only includes data for the GP practices (out-of-hours and other provider prescribing has been omitted). This provides a good overview of the number of antibiotics that were prescribed but never issued, providing assurance the data from the clinical systems mirrors ePACT data.

(please see full project pack for chart)